This inventor holds 2 USPTO granted patents. Top assignee: Regents of the University of Minnesota. Active years: 1995-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995-2003
Title: Sandra L. Olmsted: Innovator in Kappa Opioid Receptor Antagonists
Introduction
Sandra L. Olmsted is a prominent inventor based in Richfield, MN (US). She has made significant contributions to the field of pharmacology, particularly in the development of kappa opioid receptor antagonists. With a total of 2 patents to her name, her work is recognized for its potential impact on pain management and addiction treatment.
Latest Patents
Her latest patents focus on selective kappa opioid receptor antagonists. These compounds are characterized by a specific formula that includes various alkyl and aryl groups, which enhance their effectiveness. The detailed structure of these compounds allows for targeted therapeutic applications, making them a valuable addition to the pharmaceutical landscape.
Career Highlights
Sandra is affiliated with the Regents of the University of Minnesota, where she continues her research and development efforts. Her work has garnered attention for its innovative approach to addressing complex medical challenges.
Collaborations
One of her notable collaborators is Philip S. Portoghese, with whom she has worked on advancing the understanding and application of kappa opioid receptor antagonists.
Conclusion
Sandra L. Olmsted's contributions to the field of pharmacology through her patents and research exemplify her commitment to innovation. Her work holds promise for improving therapeutic options in pain management and addiction treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile